Adalimumab as first-line anti-TNF treatment in ulcerative colitis. A "real-life" observational studyR. Lorente,C. Verdejo,O. Roncero,D. Lopez,P. Robledo, A. Bouhmidi,D. HerviasJOURNAL OF CROHNS & COLITIS（2015）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
